MyAverix Finance
US · Healthcare
Evolus Inc (EOLS)
Drug Manufacturers - Specialty & Generic
Evolus Inc (EOLS) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EOLS
Evolus Inc (EOLS) — FAQ
What is EOLS's P/E ratio?
The price-to-earnings (P/E) ratio for Evolus Inc (EOLS) is 18.00 (data as of 2026-03-24).
Does Evolus Inc pay a dividend?
Dividend yield is not available in the current snapshot for Evolus Inc (EOLS). Check the MyAverix Finance app for the latest dividend data.
What sector is Evolus Inc in?
Evolus Inc (EOLS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is EOLS listed on?
EOLS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.